Cargando…
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β
Chronic inflammation has been recognized as a risk factor for the development and maintenance of malignant disease. Cytokines such as interleukin-6 (IL-6), oncostatin M (OSM), and interleukin-1 beta (IL-1β) promote the development of both acute and chronic inflammation while promoting in vitro metri...
Autores principales: | Tawara, Ken, Scott, Hannah, Emathinger, Jacqueline, Wolf, Cody, LaJoie, Dollie, Hedeen, Danielle, Bond, Laura, Montgomery, Paul, Jorcyk, Cheryl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459341/ https://www.ncbi.nlm.nih.gov/pubmed/31007849 http://dx.doi.org/10.18632/oncotarget.26699 |
Ejemplares similares
-
Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion()()
por: Tawara, Ken, et al.
Publicado: (2018) -
The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation
por: Goyden, Jake, et al.
Publicado: (2015) -
OSM-induced CD44 contributes to breast cancer metastatic potential through cell detachment but not epithelial-mesenchymal transition
por: Covert, Hunter, et al.
Publicado: (2019) -
The clinical relevance of OSM in inflammatory diseases: a comprehensive review
por: Wolf, Cody L., et al.
Publicado: (2023) -
OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung
por: Tawara, Ken, et al.
Publicado: (2018)